Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines
Fereshteh Rahdan, Fatemeh Abedi, Hassan Dianat-Moghadam, Maryam Zamani Sani, Mohammad Taghizadeh, Effat Alizadeh · 2024
Read Autophagy-based therapy for hepatocellular carcinoma: from standard treatments to combination therapy, oncolytic virotherapy, and targeted nanomedicines by Fereshteh Rahdan, Fatemeh Abedi, Hassan Dianat-Moghadam, Maryam Zamani Sani, Mohammad Taghizadeh, Effat Alizadeh (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11611955.txt.
Description
Rahdan and five co-authors review autophagy based therapy for liver cancer, in work from twenty twenty-four. Hepatocellular carcinoma is a major cause of death worldwide. Autophagy, the cell self eating system, plays a complex role in how this cancer starts and responds to drugs.
Targeting autophagy with standard drugs has opened new options, the authors note. Resistance and an immune suppressing tumor setting limit gains. Reviews here cover combined therapy, virus based therapy that kills tumor cells, and targeted nanomedicines that deliver drugs to the tumor. Precise delivery matters so healthy tissue is spared while tumor doses stay high.
Catalog record
| CREATOR | Fereshteh Rahdan, Fatemeh Abedi, Hassan Dianat-Moghadam, Maryam Zamani Sani, Mohammad Taghizadeh, Effat Alizadeh |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 64 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |